lack [qlco]
Simvastatin [orch, phsu]
Insulin Sensitivity [patf]
Type 2 [clas]
diabetic [fndg]
Patients [podg]
Hypercholesterolaemia [dsyn]
DOUBLE BLIND [resa]
randomized [resa]
placebo controlled study [inpr, resa]
cross over [genf]
Evaluate [ftcn]
effects [qlco]
Simvastatin [orch, phsu]
Serum lipids NOS [lbpr]
Insulin Sensitivity [patf]
Type 2 [clas]
DIA [gngm]
Patients [podg]
Hypercholesterolaemia [dsyn]
Methods [inpr]
DOUBLE BLIND [resa]
randomized [resa]
placebo-controlled [resa]
Cross-Over Study [resa]
RUN-IN [tmco]
eligible [idcn]
Type 2 [clas]
diabetic [fndg]
Patients [podg]
Hypercholesterolaemia [dsyn]
randomized [resa]
Receive [qlco]
Simvastatin [orch, phsu]
placebo [topp]
3 Months [tmco]
exchanging [socb]
treatment [ftcn]
3 Months [tmco]
blood samples [bdsu]
Taken [cnce]
Monthly [tmco]
intervals [tmco]
Measure [qnco]
Serum lipids NOS [lbpr]
Index [inpr]
glycemia [carb]
Euglycaemic Clamp [resd]
Insulin [aapp, horm, phsu]
Performed [ftcn]
months [tmco]
Insulin Sensitivity [patf]
Amount [qnco]
Glucose [bacs, carb, phsu]
>90 [qnco]
Clamp [medd]
M NOS [aapp, imft]
Values [qlco]
Serum insulin [lbpr]
>90 [qnco]
Measured [qlco]
M NOS [aapp, imft]
M NOS [aapp, imft]
Ratio [qnco]
Represent [acty]
In Vivo [spco]
Insulin Sensitivity [patf]
Subject [grup]
Simvastatin [orch, phsu]
Reduced [qlco]
serum cholesterol [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
Altered [ftcn]
glycemia [carb]
M NOS [aapp, imft]
Values [qlco]
M NOS [aapp, imft]
Ratios [qnco]
Group [idcn]
Drug effect [ftcn]
Insulin Sensitivity [patf]
Identified [qlco]
Conclusions [idcn]
Simvastatin [orch, phsu]
Reduced [qlco]
serum cholesterol [lbpr]
Low density lipoprotein cholesterol level [lbpr]
Alteration [idcn]
Insulin Sensitivity [patf]
Type 2 [clas]
diabetic [fndg]
Patients [podg]
Hypercholesterolaemia [dsyn]
